Stocks›Healthcare›WVE

WVE

WAVE LIFE SCIENCES LTD.

NasdaqResearch view

$3.88+4.86%

Oct 1 close · 1D EOD · Databento

HealthcarePharmaceutical PreparationsSmall-capSEC EDGAR FY 2025-12-31

What happened

Daily closes · dots are Wire stories

What’s next

Expected around late October, going by its own filing history. The company has not announced a date yet. Its matching report came Nov 10, 2025 and Nov 12, 2024, before the open.

Last report

Jul 30, 2026−0.86%

before the open

Last 4, next close

median 3.25% either way

up 3 of 4

Every report since 2023 →

DateEventSourceNext close

Jul 30Earnings release, before the open · 8-KSEC EDGARSEC EDGAR ↗−0.86%

Next close = the first close after the event against the close before it. Prior-session closes only; not a call, not advice.

What happened · big days

20 big days in a year, and what we hold on each

A big day is a close more than 6.78% from the one before, three times WVE’s median day (2.26%). On 0 of the 20, its peer group moved the same way at least half as far. We show what we hold. We never name a cause.

every other trading daya big day, numbered in the list below±6.78%Hover a bar for its day. Click a big day to open it.

Shaded: since our stories began, Jun 10. Tap a bar for its day.

#DayWVEWhat we hold that dayGroup (median of 4) · each

1 Oct 9, 2025+11.43%
Before our storiesgroup +0.9%, did not move with it
1Oct 9, 2025+11.43%
Before our stories
+0.9% did not move with itMRK +1.3 · LLY +1.1 · JNJ +0.7 · ABBV −0.2
2 Oct 10, 2025−7.20%
Before our storiesgroup −1.0%, did not move with it
2Oct 10, 2025−7.20%
Before our stories
−1.0% did not move with itLLY −2.6 · MRK −1.7 · JNJ −0.2 · ABBV −0.1
3 Oct 22, 2025−8.54%
Before our storiesgroup +0.3%, did not move with it
3Oct 22, 2025−8.54%
Before our stories
+0.3% did not move with itABBV −1.2 · MRK −0.0 · JNJ +0.6 · LLY +1.6
4 Oct 27, 2025+6.87%
Before our storiesgroup +0.1%, did not move with it
4Oct 27, 2025+6.87%
Before our stories
+0.1% did not move with itMRK +0.6 · LLY +0.1 · ABBV +0.0 · JNJ −0.1
5 Oct 29, 2025+8.83%
Before our storiesgroup −0.7%, did not move with it
5Oct 29, 2025+8.83%
Before our stories
−0.7% did not move with itJNJ −0.2 · MRK −0.5 · LLY −0.8 · ABBV −1.1
6 Oct 31, 2025+8.92%
Before our storiesgroup −0.2%, did not move with it
6Oct 31, 2025+8.92%
Before our stories
−0.2% did not move with itLLY +2.2 · JNJ −0.1 · MRK −0.3 · ABBV −4.5
7 Nov 3, 2025−8.08%
Before our storiesgroup −2.1%, did not move with it
7Nov 3, 2025−8.08%
Before our stories
−2.1% did not move with itMRK −4.1 · ABBV −2.8 · JNJ −1.4 · LLY +3.9
8 Nov 10, 2025−10.31%
Resultsgroup +0.8%, did not move with it
8Nov 10, 2025−10.31%
ResultsFirst close after the Nov 10 results filing
+0.8% did not move with itABBV −0.2 · MRK +0.5 · JNJ +1.0 · LLY +4.6
9 Dec 8, 2025+147.26%
Before our storiesgroup −1.0%, did not move with it
9Dec 8, 2025+147.26%
Before our stories
−1.0% did not move with itJNJ −0.1 · MRK −0.8 · LLY −1.3 · ABBV −1.3
10 Dec 9, 2025+15.06%
Before our storiesgroup −1.2%, did not move with it
10Dec 9, 2025+15.06%
Before our stories
−1.2% did not move with itABBV −0.1 · JNJ −0.8 · LLY −1.5 · MRK −2.1
11 Dec 11, 2025−17.20%
Before our storiesgroup +1.5%, did not move with it
11Dec 11, 2025−17.20%
Before our stories
+1.5% did not move with itABBV −0.5 · MRK +1.4 · LLY +1.6 · JNJ +1.7
12 Dec 22, 2025+12.45%
Before our storiesgroup +0.5%, did not move with it
12Dec 22, 2025+12.45%
Before our stories
+0.5% did not move with itMRK +3.6 · ABBV +0.5 · LLY +0.5 · JNJ +0.5
13 Feb 27, 2026−9.31%
Before our storiesgroup +3.1%, did not move with it
13Feb 27, 2026−9.31%
Before our stories
+3.1% did not move with itJNJ +2.0 · LLY +2.9 · ABBV +3.3 · MRK +3.8
14 Mar 26, 2026−49.59%
Before our storiesgroup −0.3%, did not move with it
14Mar 26, 2026−49.59%
Before our stories
−0.3% did not move with itLLY −2.1 · MRK −0.4 · JNJ −0.3 · ABBV +1.9
15 Mar 31, 2026+9.52%
Before our storiesgroup +1.9%, did not move with it
15Mar 31, 2026+9.52%
Before our stories
+1.9% did not move with itLLY +3.7 · ABBV +2.0 · MRK +1.9 · JNJ +0.8
16 Apr 28, 2026+8.36%
Resultsgroup +0.4%, did not move with it
16Apr 28, 2026+8.36%
ResultsFirst close after the Apr 28 results filing
+0.4% did not move with itJNJ +1.1 · LLY +0.7 · ABBV +0.2 · MRK −0.2
17 Jun 2, 2026−9.11%
Before our storiesgroup +0.1%, did not move with it
17Jun 2, 2026−9.11%
Before our stories
+0.1% did not move with itLLY −1.7 · JNJ −0.3 · MRK +0.4 · ABBV +1.2
18 Jul 2, 2026+7.19%
Nothing on WVEgroup +3.5%, did not move with it
18Jul 2, 2026+7.19%
Nothing on WVENo WVE story, brief or results filing in our record that day
+3.5% did not move with itABBV +4.0 · JNJ +3.6 · MRK +3.3 · LLY +1.9
19 Aug 11, 2026−16.89%
Nothing on WVEgroup −0.6%, did not move with it
19Aug 11, 2026−16.89%
Nothing on WVENo WVE story, brief or results filing in our record that day
−0.6% did not move with itLLY −1.4 · JNJ −0.8 · MRK −0.4 · ABBV +0.8
20 Sep 23, 2026−9.20%
Nothing on WVEgroup −0.8%, did not move with it
20Sep 23, 2026−9.20%
Nothing on WVENo WVE story, brief or results filing in our record that day
−0.8% did not move with itMRK −1.9 · LLY −1.6 · ABBV −0.1 · JNJ −0.0

A story on the same day is not a cause, and a group move is not proof either. Group: the median of LLY, JNJ, ABBV and MRK that day, the largest companies in WVE’s SEC industry; “moved with WVE” means the same direction and at least half the size.

What’s next · results

Before the next report: what the first day after the last four did

Six trading days after each results filing (SEC 8-K, Item 2.02). WVE reports before the open, so day 1 is that day’s close. 1 of 4 times, day 6 ended on the same side as day 1.

Reported Jan 12, 2026

day 1+0.51%day 6−0.14%

Reported Feb 26, 2026

day 1+5.64%day 6−9.22%

Reported Apr 28, 2026

day 1+8.36%day 6+3.46%

Reported Jul 30, 2026

day 1−0.86%day 6+3.61%

Next report: expected late OctoberEstimated from the dates of its last four results filings. Not announced. Since the Jul 30 report: −33.22%. Four reports is a small sample.

Every report since 2023 →

Each line is WVE’s close against its close before the filing, on licensed end-of-day closes. What happened after each report, not a forecast; a move on the day is not a cause.

The numbers · FY2025, filed

SEC EDGAR

Market cap$729M

Revenue$42.7M−60.50%

Net income$-204.4M

EPS, diluted$-1.21−72.90%

Operating margin-504.1%

Return on equity-39.4%

All filed figures

Snapshot

SEC EDGAR · FY 2025-12-31

SectorHealthcare

Market Cap$729.1M

Enterprise Value$127.0M

Income$-204.4M

Sales$42.7M

Book/sh$2.63

Cash/sh$3.06

Dividend TTM—

Payout—

Employees—

IPO—

Quick Ratio—

Current Ratio6.47

Debt/Eq—

EPS (ttm)$-1.21

EPS this Y-72.9%

EPS past 3/5Y—

Sales past 3/5Y127.1%

EPS Y/Y TTM-72.9%

Sales Y/Y TTM-60.5%

Shs Outstand197.05M

ROA-32.0%

ROE-39.4%

ROIC—

Gross Margin—

Oper. Margin-504.1%

Profit Margin-478.3%

Every figure here is filed with the SEC. Valuation and estimate metrics (P/E, PEG, EV/EBITDA, price targets, forward EPS) are omitted until our market-data feed is licensed for display — we’d rather show fewer numbers than blank ones. Deeper lines (cash flow, balance sheet) below.

Revenue by fiscal year

$41.0M

FY21

$3.6M

FY22

$113.3M

FY23

$108.3M

FY24

$42.7M

FY25

Operating leverage — margins

GrossOperatingNet

Financials, annual · income and cash flowSEC EDGAR · open ▸

Financials — annual

SEC EDGAR · last 5 FY · tap a row to explain it

USD	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$41.0M	$3.6M	$113.3M	$108.3M	$42.7M
Gross Profit	—	—	—	—	—
Operating Income	$-127.0M	$-162.7M	$-68.0M	$-110.4M	$-215.4M
Net Income	$-122.2M	$-161.8M	$-57.5M	$-97.0M	$-204.4M
Diluted EPS	$-2.36	$-2.05	$-0.54	$-0.70	$-1.21
Operating Cash Flow	$-89.0M	$-127.8M	$-19.4M	$-151.0M	$-187.5M
Free Cash Flow	$-89.6M	$-129.1M	$-20.5M	$-152.0M	$-188.2M

Same industry

WVE against four drug peers, a year at 100

WVE is down 45.7% in a year. Merck is up 61.2%, Johnson & Johnson 37.1%, Eli Lilly 36.9% and AbbVie 11.1%. All four did more. Weekly closes, Oct 3, 2025 = 100, on a log scale, so the same percentage move is the same height on every line.

Share this chart

WVE −45.7%. Merck +61.2%, Johnson & Johnson +37.1%, Eli Lilly +36.9%, AbbVie +11.1%. Weekly closes, Oct 3, 2025 = 100, log scale.

Share this chart

End-of-day closes (Databento EOD), the last close of each week. The four peers are the largest US-listed companies by market value in WVE’s SEC industry (Pharmaceutical Preparations) with a year of closes. It shows what the closes did; a move here is not a cause, a forecast or a call.

Same industry

In the screener →

LLY$1.09T JNJ$638.0B ABBV$462.3B MRK$358.5B ABT$171.0B PFE$162.6B VRTX$132.5B BMY$127.5B

Follow the news. Track the move.

WVE story timeline

Company updates and connected market context, with the dated price move attached.

Stories

Direct

WVE direct/Consumer

Oct 1

Wave Life Sciences Announces FDA Feedback Supports Registrational Pathway for WVE-006 (RNA Editing) in AATD

Wave Life Sciences said FDA feedback supports a single two-year registrational trial for WVE-006 in alpha-1 antitrypsin deficiency, with a one-year interim analysis that could support accelerated approval based on biomarkers. The plan gives investors a defined regulatory route, but the trial design still leaves clinical validation and execution ahead.

Price history unavailable

GlobeNewswire · 1d ago

View both sides →